Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20N6O3S |
InChIKeyIJEDYDGSAXSVPY-GFCCVEGCSA-N |
CAS Registry2907782-78-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | China | 25 Jul 2024 |





